Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-01-20 | New | $3,300,000 | $3,300,000 | Equity Only | 06b | SEC link |
| 2024-04-01 | New | $61,547,439 | $61,547,439 | Equity Only | 06b | SEC link |
| 2023-03-03 | New | $1,461,324 | $1,461,324 | Equity Only | 06b | SEC link |
| 2022-01-04 | New | $3,000,000 | $3,000,000 | Equity Only | 06b | SEC link |
| 2021-10-25 | New | $3,000,000 | $3,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Gbola Amusa | Director |
| Merav Bassan | Executive |
| Susan Blum | Director |
| Avi Gabay | Executive |
| Jesse Goodman | Director |
| Russell Greig | Director |
| Jonas Grossman | Director |
| Jonathan Leff | Director |
| Gregory Merril | Director |
| Alan Moses | Director |
| Assaf Oron | Executive |
| Sailaja Puttagunta | Executive |
| Paul Sekhri | Director |
| Jonathan Solomon | Director, Executive |
| Lynne Sullivan | Director |
| Eddie Williams | Director |
| Edward Williams | Director |
| Marina Wolfson | Executive |